[Hepatectomy vs. sorafenib in advanced hepatocellular cancer]
Chirurgie (Heidelb)
.
2022 Jun;93(6):604-605.
doi: 10.1007/s00104-022-01657-0.
Epub 2022 May 19.
[Article in German]
Authors
Sandra Nickel
,
Michael Ardelt
1
,
Utz Settmacher
Affiliation
1
Klinik für Allgemein‑, Viszeral- und Gefäßchirurgie, Am Klinikum 1, 07747, Jena, Deutschland. michael.ardelt@med.uni-jena.de.
PMID:
35925097
DOI:
10.1007/s00104-022-01657-0
No abstract available
MeSH terms
Carcinoma, Hepatocellular* / drug therapy
Hepatectomy
Humans
Liver Neoplasms* / drug therapy
Phenylurea Compounds / therapeutic use
Sorafenib / therapeutic use
Substances
Phenylurea Compounds
Sorafenib